90 likes | 108 Vues
Next Generation Sequencers Market segmentation by technology would help in understanding strategies adopted by companies as well as the emerging technologies in the market. An in-depth analysis of the applications of this market identifies business opportunities. Geographic distribution of the market would help in discovery of untapped regions. Key drivers and opportunities enable identification of areas of growth.<br>
E N D
Next Generation Sequencers Market is Set to Change The Face Of Healthcare Industry Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2017-2023
Next Generation Sequencers Market Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few DNA strands. This technology allows the rapid sequencing of millions of base pairs of DNA spanning entire genomes. The launch of new generation sequencers has opened up various markets, especially in the field of research, diagnostics and personalized medicine. The major drivers for this market are the need for constant developments with the aim of achieving an increased accuracy at a lower cost. The increasing applications for this technology, its potential as a replacement for microarray technology, decreasing costs and faster turnaround time are other factors driving this market.
Next Generation Sequencers Market by Technology Next Generation Sequencers Market can be segmented based on the type of technology used such as Sequencing by synthesis, Ion semiconductor, sequencing, Sequencing by ligation, Pyrosequencing, Single molecule, real-time (SMRT) Sequencing, Nanopore Sequencing. Nanopore Sequencing is the recent advancement in this category and is expected to lower the cost of sequencing.
Competitive Analysis of Next Generation Sequencers Market Some of the the key players in this market are Illumina, Life Technologies, Roche, Applied Biosystems, Pacific Biosciences, Complete Genomics, Oxford Nanopore Technologies and others. In 2013, The UAB Research Foundation licensed its nanopore technology to Illumina, a giant in the Next Generation Sequencing Market. Nanopore technology is the latest technological development in Next Generation Sequencing. With this deal, Illumina would add to its existing technologies and maintain a competitive edge in the market.
High Level analysis of Next Generation Sequencers Market The report describes the segments of next generation sequencers market. Porters five force model helps in analyzing the bargaining power of suppliers and buyers, as well as the threat posed by new entrants. Market is analyzed by the strategic moves made by competitors, which will enable stakeholders to make decisions. Investments and partnerships, especially with researchers coming up with new technologies would enable companies to stay ahead in this competitive market.
Key Benefits of Next Generation Sequencers Market • Market segmentation by technology would help in understanding strategies adopted by companies as well as the emerging technologies in the market An in-depth analysis of the applications of this market identifies business opportunities Geographic distribution of the market would help in discovery of untapped regions Key drivers and opportunities enable identification of areas of growth. • • •
Next Generation Sequencers Market Segments Next Generation Sequencers Market by Technology • • • • • • Sequencing by synthesis Ion semiconductor sequencing Sequencing by ligation Pyrosequencing Single molecule, real-time (SMRT) Sequencing Nanopore Sequencing Next Generation Sequencers Market by Application • • • • • • Drug Discovery Biomarker Discovery Diagnostics Agriculture and Animal Research Metagenomics Personalized Medicine
Next Generation Sequencers Market North America Europe Asia-Pacific LAMEA
Next Generation Sequencers Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-toc- and-sample/263 Follow Us On